Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Corvus Pharmaceuticals Inc (NASDAQ: CRVS) was $8.19 for the day, down -3.87% from the previous closing price of $8.52. In other words, the price has decreased by -$3.87 from its previous closing price. On the day, 2.35 million shares were traded. CRVS stock price reached its highest trading level at $8.51 during the session, while it also had its lowest trading level at $7.79.
Ratios:
Our analysis of CRVS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.92 and its Current Ratio is at 0.92. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on August 18, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
On May 27, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $10.Cantor Fitzgerald initiated its Overweight rating on May 27, 2021, with a $10 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 06 ’24 when Jones William Benton bought 20,000 shares for $1.73 per share. The transaction valued at 34,624 led to the insider holds 153,773 shares of the business.
MILLER RICHARD A MD bought 577,634 shares of CRVS for $1,000,000 on May 06 ’24. The President and CEO now owns 577,634 shares after completing the transaction at $1.73 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRVS now has a Market Capitalization of 526267264 and an Enterprise Value of 508283872.
Stock Price History:
Over the past 52 weeks, CRVS has reached a high of $10.00, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is 19.90%, while the 200-Day Moving Average is calculated to be 138.39%.
Shares Statistics:
CRVS traded an average of 663.10K shares per day over the past three months and 1202080 shares per day over the past ten days. A total of 64.26M shares are outstanding, with a floating share count of 49.95M. Insiders hold about 22.27% of the company’s shares, while institutions hold 28.57% stake in the company. Shares short for CRVS as of 1730332800 were 2925030 with a Short Ratio of 4.41, compared to 1727654400 on 2149980. Therefore, it implies a Short% of Shares Outstanding of 2925030 and a Short% of Float of 5.8000002.
